Diversity, women and streaming dominate Oscar nominations in strange movie year

Reuters

Exclusive: AbbVie in talks to sell $5 billion women’s drugs portfolio – sources

U.S. drugmaker AbbVie Inc is in discussions to sell a roughly $5 billion portfolio of women’s drugs acquired last year through its $63 billion purchase of Botox maker Allergan Plc, sources familiar with the matter told Reuters. The move revives a process to sell the business, which makes the Lo Loestrin Fe birth control pill, that Allergan started in 2018 only to ditch five months before being acquired by AbbVie in 2019. AbbVie is working with investment bank Morgan Stanley on an auction process that has attracted interest from private equity firms including CVC Capital Partners, said the sources, speaking on condition of anonymity.

Read More